Watchlist Price Alert

LENZ Therapeutics Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

29.66

0.78 (2.70%)

At close: May 02, 2025, 3:59 PM

31.50

6.20%

After-hours: May 02, 2025, 05:04 PM EDT

LENZ Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-49.77M	-124.65M	-101.05M	-70.76M	-68.37M	-109K
Depreciation & Amortization	58K	2.41M	8.35M	734K	121K	n/a
Stock-Based Compensation	6.37M	1.34M	721K	196K	n/a	n/a
Other Working Capital	-8.81M	-36.87M	-7.4M	-4.32M	1.11M	22K
Other Non-Cash Items	-2.95M	70.12M	28.43M	19.32M	57.47M	92K
Deferred Income Tax	n/a	n/a	-17.22M	161K	n/a	n/a
Change in Working Capital	-13.09M	-39.22M	-7.21M	-2.5M	1.71M	10K
Operating Cash Flow	-59.39M	-90.01M	-87.98M	-52.85M	-8.72M	-19K
Capital Expenditures	-468K	-10.86M	-6.59M	-5.74M	-1.54M	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-241.91M	-28.13M	-405.52M	n/a	n/a	n/a
Sales Maturities Of Investments	87.9M	263.43M	170.25M	n/a	n/a	n/a
Other Investing Acitivies	n/a	1.9M	n/a	n/a	n/a	n/a
Investing Cash Flow	-154.48M	226.35M	-241.86M	-5.74M	-1.54M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-67K	-79K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	119.49M	n/a	n/a	306K	n/a	n/a
Financial Cash Flow	199M	190K	597K	417.47M	30.08M	n/a
Net Cash Flow	-14.87M	138.13M	-329.25M	357.16M	19.81M	-19K
Free Cash Flow	-59.86M	-100.86M	-94.57M	-58.59M	-10.27M	-19K